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Abstract:  The most frequently used technique to study the expression profile of genes 
involved in common neurological disorders is quantitative real-time RT-PCR, which 
allows the indirect detection of very low amounts of selected mRNAs in tissue samples. 
Expression analysis by RT-qPCR requires an appropriate normalization to the expression 
level of genes characterized by a stable, constitutive transcription. However, the 
identification of a gene transcribed at a very stable level is difficult if not impossible, since 
significant fluctuations of the level of mRNA synthesis often accompanies changes of cell 
behavior. The aim of this study is to identify the most stable genes in postmortem human 
brain samples of patients affected by Alzheimer’s disease (AD) suitable as reference genes. 
The experiments analyzed 12 commonly used reference genes in brain samples from eight 
individuals with AD and seven controls. After a careful analysis of the results calculated by 
geNorm and NormFinder algorithms, we found that CYC1 and EIF4A2 are the best 
reference genes. We remark on the importance of the determination of the best reference 
genes for each sample to be analyzed and suggest a practical combination of reference 
genes to be used in the analysis of human postmortem samples.  
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1. Introduction  
Alzheimer’s disease (AD) is a progressive neurodegenerative pathology affecting hippocampus, 
temporal and/or frontal cerebral cortex lobes. It causes a selective loss of cortical neurons leading to 
the intracellular deposition of Tau (microtubule-associated protein tau NM_001123066.3) protein 
neurofibrillary tangles and to the extracellular deposition of β-amyloid peptide (Aβ) in form of senile 
plaques [1]. One of the main concerns of AD research practices is the lack of sources of experimental 
samples. Indeed, the available brain samples derive solely from autopsies and, as a consequence, carry 
several limitations. Thus, the low quality of RNA from autopsy samples has been always an important 
issue, since the vast majority of experiments involve the analysis of genes expression [2]. In this 
context the most frequently used approach to study the expression profile of genes involved in AD is 
quantitative real-time RT-PCR (RT-qPCR), which allows the indirect detection of very low amounts of 
selected messenger RNAs in tissue samples. Unfortunately, the identification of a gene transcribed at a 
stable level is very difficult if not impossible since significant fluctuations of the level of synthesis 
often accompany changes of cell behavior [3–5]. Thus, an ideal reference gene for data normalization 
would be consistently expressed in all samples in any experimental condition, regardless of the tissue 
type and possible disease state whereas its quantitative expression should be comparable to that of the 
target gene [4,6]. In this context it is reasonable to conclude that there is not a universal reference gene 
suitable for different experimental conditions and that individual cases should contemplate a careful 
evaluation and validation of several reference genes prior to choosing the appropriate one [6,7]. 
Indeed, alterations of the reference gene expression between target samples and their controls may lead 
to a significant alteration of the results [8]. 
The vast majority of RT-qPCR expression profiles found in the literature (including our recent 
experiments) uses GAPDH (glyceraldehyde-3-phosphate dehydrogenase, NM_002046.3) as a 
reference gene for normalization. In the specific case of neurodegeneration, a series of contributions 
aimed to determine the suitability of this gene demonstrated an abnormal aggregation of GAPDH 
protein product in the nucleus of cells from AD patients together with an increased activity of this 
enzyme in the diseased tissues, keeping in line with a direct and/or indirect correlation of GAPDH with 
the neurodegenerative process [9,10]. On the contrary, although neither alterations of the enzymatic 
activity nor aberrant capacity to aggregate directly affect RT-qPCR determinations, the mRNA level 
has been found to be slightly decreased in AD tissues with respect to their non-diseased counterparts. 
Therefore, altogether a decreased synthesis of GAPDH mRNA, an increased aggregation of GAPDH 
protein and an augmented activity of GAPDH enzymatic activity reported in neurodegenerated tissues 
suggest a possible involvement of this enzyme in neurodegenerative pathologies and suggest the use of 
a different reference gene in these samples.  Int. J. Mol. Sci. 2011, 12 5463 
 
In this work we report the comparative analysis of 12 different genes as putative reference genes for 
postmortem AD samples and controls in RT-qPCR practices and provide evidence for the usefulness 
of CYC1 and EIF4A2 in these experiments, excluding specific references with bad performances. 
2. Results 
In order to compare expression levels of target genes in different tissues at the same time, it is 
crucial to normalize all samples by the same set of reference genes. For the evaluation of potential 
references, we used the geNorm Housekeeping Gene Selection Kit (PrimerDesign-Eppendorf, 
Hamburg, Germany) to evaluate 12 commonly used reference genes in different human brain samples 
from 8 postmortem cerebral cortices of individuals with AD and 7 controls (Table 1). 
Table 1. Description of the Control and Alzheimer’s disease (AD) subjects (sex, diagnosis, 
age, postmortem delay, death status, precise location of the specimen). Abbreviations:   
TC = temporal cortex; FC = frontal cortex; ND = not determined. 
Case 
Number 
Sex Diagnosis 
Age 
(Y.O.) 
Postmortem Delay 
(Hours) 
Death Status  Area 
Control    
90-234  M  Prostatic carcinoma  77  5  Cognitively Normal  FC 
CTR 3  ND  Heart Infarct  65  10  Cognitively Normal  FC 
A93-300 M  Control  88  4  Cognitively  Normal  TC 
CTR7  ND  Lung disease  69  7  Cognitively Normal  ND 
0916 ND  Control  70  ND  Cognitively  Normal  ND 
CTR 8  ND  Control  ND  ND  Cognitively Normal  ND 
A94-207   M  Multiple infarct basal ganglia  86  4  Cognitively Normal  ND 
AD cases   
801 ND  AD  78  ND  Dementia  ND 
AD02-011 ND  AD  64  14  Dementia  ND 
AD 94-382  ND  AD  81  2.05  Dementia  TC 
AD 007  ND  AD  69  ND  Dementia  ND 
AD171 ND  AD  87  15  Dementia  ND 
969 F  AD  82 1.05  Dementia  FC 
977 M  AD  80  6.03  Dementia  FC 
A92-404 M  AD  69  6.05  Dementia  TC 
As shown in Table 2, the reference genes tested were RN18S1 (18S ribosomal RNA subunit), 
ACTB (beta-actin), TOP1 (DNA topoisomerase type I), ATP5B (ATP synthase, H+ transporting, 
mitochondrial F1 complex, beta polypeptide), B2M (beta-2 microglobulin), CYC1 (Cytochrome c1), 
EIF4A2 (eukaryotic translation initiation factor 4a2), GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase), RPL13A (ribosomal protein L13a), SDHA (succinate dehydrogenase complex,   
subunit A), UBC (ubiquitin C) and YHWAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta polypeptide).  Int. J. Mol. Sci. 2011, 12 5464 
 
Table 2. Candidate reference genes for normalization in different brain samples (AD cases 
and controls) ranked according to their expression stability by geNorm and NormFinder. 
     geNorm NormFinder 
Gene name  Gene  
symbol 
Genebank  
accession 
Ranking 
order 
Average  
M value 
Ranking 
order 
Stability
value 
Topoisomerase (DNA) I  TOP1 NM_003286.2 1  0.75  6  0.577 
Beta-2-microglobulin B2M  NM_004048.2  1  0.75  11  0.651 
Eukaryotic translation initiation factor 4A2  EIF4A2  NM_001967.3  3  0.84  2  0.218 
Ribosomal protein L13a  RPL13A  NM_012423.2  4  0.9  8  0.596 
Cytochrome c-1  CYC1  NM_001916.3  5  1.01  1  0.217 
Actin, beta  ACTB  NM_001101.3  6  1.09  5  0.413 
Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)  SDHA  NM_004168.2  7  1.22  4  0.365 
Ubiquitin C  UBC  NM_021009.5  8  1.29  6  0.577 
Glyceraldehyde-3-phosphate dehydrogenase GAPDH  NM_002046.3  9  1.33  10  0.623 
Tyrosine 3-monooxygenase/tryptophan  
5-monooxygenase activation protein, zeta polypeptide 
YWHAZ NM_001135699.1 10  1.4  3  0.347 
ATP synthase, H+ transporting, mitochondrial F1 complex, 
beta polypeptide 
ATP5B NM_001686.3  11  1.46  12  0.683 
RNA, 18S ribosomal 1  RN18S1  NR_003286.2  12  1.57  9  0.621 
The total RNA obtained from 15 different human brain samples were analyzed for their purity and 
the concentration by measuring the absorbance ratio at 260/280 nm. Total RNA samples were shown 
to be free of protein contaminants with values between 1.6 and 2 (data not shown).  
We also tested RNA integrity by electrophoresis on 2% agarose gel as indicated in the MIQE 
guidelines [11] (data not shown). 
Equal amounts of RNA extracted from samples were reverse transcribed and used as a template for 
RT-qPCR according to the manufacturer’s protocol (PrimerDesign-Eppendorf). To evaluate the 
expression stability of the selected reference genes, the Cq values of the sample collection were 
averaged to obtain raw Cq values. As shown in Figure 1, the 12 HKGs demonstrated a wide range of 
expression level, from the lowest Cq of 17.1 for the RN18S1 (18S ribosomal RNA subunit) to the 
highest Cq of 46.75 for the SDHA (succinate dehydrogenase complex, subunit A). This is an ideal 
condition because the levels of expression of normalizers span a broad range of expression levels and 
should be similar to genes of interest.   Int. J. Mol. Sci. 2011, 12                 
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Figure 1. Expression levels of candidate reference genes. Values are given as quantitative 
real-time RT-PCR cycle threshold (Cq) values for 12 candidate reference genes in 15 
human brain samples (○: Control; ♦: AD).  
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The Cq values were then transformed into relative quantification data using the 2(
−deltaCq) method 
and then analyzed by geNorm [12] and NormFinder [13]. 
GeNorm is a statistical algorithm designed to analyze the expression stability of a list of selected 
reference genes in all samples, and ranking them according to gene stability measurements (M). In this 
approach, the M value is defined as the mean pairwise variation of a gene with all the other reference 
genes in a given set of samples so that a low M value is indicative of more stable expression [12]. In 
our samples we found that the M values for the genes (from the least stable to the most stable) were the 
following: RN18S1, ATP5B, YWHAZ, GAPDH, UBC, SDHA, ACTB, CYC1, RPL13A, EIF4A2, 
TOP1 and B2M (Figure 2A and Table 2). Previous studies defined M = 1.5 as an acceptable cut-off for 
selection of RT-qPCR reference genes [14,15]. All the genes analyzed here reached high expression 
stability, with all the M values below the default limit of 1.5, with the exception of RN18S1   
(M = 1.57). In this condition, with the final aim to select the best, intermediate and the worst reference 
genes based on their expression stability, we divided the M value range arbitrarily in three groups. As 
shown in Figure 2A, the most stable genes (0.75 < M value < 1.02) were CYC1, RPL13A, EIF4A2, 
B2M and TOP1. The intermediate stable genes (1.02 < M value < 1.29) were UBC, SDHA and ACTB, 
whereas the group of genes characterized by a fluctuating expression (1.29 < M value < 1.57) were 
RNA18S1, ATP5B, YWHAZ and GAPDH.  
Next, the geNorm program was used to calculate the pairwise variation (V) among the reference 
genes providing an estimate of the optimum number of reference candidates to be used for data 
normalization (Figure 2B). The pairwise variation (Vn/n+1) showed the effect of adding further 
reference genes on the normalization factor (that is calculated as the geometric mean of the expression 
values of the selected reference genes). When analyzing reference genes for our samples, we observed 
that the stepwise inclusion of individual reference genes showed an initial decrease until a minimal 
value (V9/10). The next addition of other reference genes determined an increase of Vn/n+1, suggesting Int. J. Mol. Sci. 2011, 12                 
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that there was a decrease of expression stability, due to the inclusion of a relatively unstable eleventh 
gene. This particular curve suggests that inclusion of either too few or too many reference genes could 
lead to erroneous normalization. Therefore, for the optimal normalization of data in this experimental 
setting, it would be theoretically appropriate to use 10 reference genes (BM2, TOP1, EIF4A2, 
RPL13A, CYC1, ACTB, SDHA, UBC, GAPDH and YWHAZ) (Figure 2B). 
Figure 2. Expression stability of 12 reference genes in human brain samples. (A) Average 
expression stability values (M) of 12 candidate genes from the least stable to the most 
stable, calculated by geNorm; (B) Determination of optimal number of reference genes 
required for accurate normalization based on pairwise variation (Vn/Vn+1) between 
candidate genes; (C) Stability of different reference gene candidates according to 
NormFinder; (D) Determination of the optimal number of control genes for   
normalization data on the calculation of the Accumulated Standard Deviation (Acc.S.D.)  
using NormFinder. 
 
In order to test and/or validate our findings, the above data were analyzed by NormFinder [13]. This 
algorithm is based on a separate analysis of the two groups of samples (in this study, AD cases and 
controls) and combined the intragroup and intergroup expression variations of the selected reference 
genes into a stability value that ranked reference genes according to their expression stability. The 
candidates with the lowest intragroup and intergroup variations give the lowest stability value and are 
therefore ranked higher. The calculated stability values of the 12 candidate genes are reported in   
Table 2 and Figure 2C. Based on NormFinder, the most stable reference gene for postmortem brain 
samples is CYC1, followed by EIF4A2, YWAHZ, SDHA, ACTB, UBC, TOP1, RPL13A, RN18S1, Int. J. Mol. Sci. 2011, 12                 
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GAPDH, B2M and ATP5B. In order to match the results obtained with NormFinder to those obtained 
with geNorm, we first divided the stability value ranges in three intervals corresponding to the most, 
intermediate and the least stable genes. The most stable genes (0.21 < stability value < 0.37) were 
SDHA, YWHAZ, EIF4A2 and CYC1. The intermediate gene (0.37 < stability value < 0.53) was 
ACTB, whereas the least stable genes (0.53 < stability value < 0.69) were ATP5B, B2M, GAPDH, 
RNA18S1, RPL13A, TOP1 and UBC. 
Next, taking advantage of NormFinder, we also calculated the Accumulated Standard Deviation 
(Acc.S.D.) as an indicator of the optimal number of reference genes to be used in the normalization 
process. Results showed that the lowest value of the Acc.S.D. (indicating the optimal number of 
reference genes) is reached when 10 reference genes are used (0.3233) (Figure 2D).  
In conclusion, the above results demonstrate that: (1) the theoretically optimal normalization is 
reached by using 10 different reference genes based on results from both algorithms; (2) since this 
number of determinations might be time consuming and expensive, the use of the combination of the 
two genes that fall in the best rank of both the algorithms (CYC1 and EIF4A2) are recommended as 
the best compromise solution for RT-qPCR determinations in human postmortem cerebral   
cortex samples. 
3. Discussion 
Quantitative real-time RT-PCR is a powerful and widely used technique for quantitative analysis of 
expression levels due to its high sensitivity, specificity, accuracy and reproducibility and to its 
suitability for the analysis of very small samples. 
This technique requires an appropriate normalization of the data in order to minimize possible 
differences between test samples due to technical variations [12]. The most commonly used approach 
for transcript normalization takes advantage of internal reference genes characterized by a stable 
expression level [16]. To this aim the vast majority of studies exploits GAPDH, β-actin, or 18S rRNA, 
although recent experiments demonstrate that their expression can vary under different experimental 
conditions [4,5]. In particular, RN18S1 has been excluded in previous studies, due to its high levels of 
expression [6,17], because such high abundance relative to a target can make RT-qPCR data analysis 
difficult [12]. Therefore, these findings suggest searching for the best reference gene for each specific 
tissue and/or sample being studied [12]. 
In this work we tested several candidate reference genes, analyzing the results with two different 
algorithms in order to determine the most stably expressed and the optimum number of reference 
candidates suitable for RT-qPCR data normalization in postmortem brain tissue samples.  
geNorm [12] and NormFinder [13] algorithms are now widely used and they are based on diverging 
mathematical approaches. geNorm analyzes the expression stability of the tested genes in all samples, 
and ranks them accordingly to gene stability measure (M). In contrast to geNorm, NormFinder 
evaluates the expression stability of each single reference gene independently from each other, and 
takes into account intra- and inter-group variations for normalization. This is very important in view of 
limited knowledge about the co-regulation of candidates in a given experimental setting. 
Although, due to their distinct statistical algorithms, the two programs used gave slightly different 
results, both suggest the (theoretically) optimal number of ten reference genes for an accurate Int. J. Mol. Sci. 2011, 12                 
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normalization in postmortem brain samples. Since the ordinary use of ten reference genes for this 
experimental setting leads to a waste of resources, we arbitrarily established cut-off scores identifying 
EIF4A2 and CYC1 as the best combination of stably expressed genes that fits with both the   
algorithms calculations.  
Altogether, the above results emphasize the importance of assessing and evaluating the stability of 
genes for each experimental condition prior to their use as reference genes, and suggest the use of two 
reference genes (EIF4A2 and CYC1) for an appropriate normalization of the RT-qPCR data in human 
brain tissues. 
4. Material and Methods  
4.1. Human Brain Samples and cDNA Preparation 
Frontal and temporal cortices from 8 AD (clinical history of disease; pathological diagnosis 
according to the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) criteria) and 7 
control cases (AD excluded by clinical history and by immunohistochemical analysis) were derived 
from P. Gambetti and Brain Bank (Case Western Reserve University, Cleveland, OH, USA) and C. 
Hulette and the Joseph and Kathleen Bryan Alzheimer’s Disease Research Center (Duke University 
Medical Center, Durham, NC, USA). Patient characteristics are summarized in Table 1.  
Small pieces (50–100 mg) of gray matter from frontal and temporal cortices were excised under 
sterile conditions. 
Total RNAs from samples were extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer’s protocol and treated with DNase (Roche, Mannheim, Germany) in 
order to remove any trace of genomic DNA. After extraction, RNA concentration was estimated 
spectrophotometrically (BioPhotometer Plus-Eppendorf, Germany) at 260 nm (A260), and purity of the 
samples was assessed by the A260/A280 ratio (A260/A280 ranging within 1.6–2, as indicated by Sambrook 
and Russel). RNA integrity was assessed by electrophoresis on 2% agarose gel as indicated in the 
MIQE guidelines [11].  
1 μg of RNA was then subjected to reverse transcription by Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche, Germany). Total RNA was denatured at 65 °C for 10 min. Then it was placed on 
ice and supplemented with a mix containing the reverse transcriptase enzyme. Reactions were carried 
out at 29 °C for 10 min, at 48 °C for 1 h and at 85 °C for 5 min. cDNA was diluted ten-fold in 
RNase/DNase-free water and stored at −20 °C.  
4.2. Quantitative Real-Time RT-PCR 
Experiments were performed using the geNorm Housekeeping Gene Selection Kit   
(PrimerDesign-Eppendorf, Hamburg, Germany). 
The total RNA from samples was measured by quantitative real-time RT-PCR in duplicate wells 
using PrimerDesign 2X Precision
TM MasterMix (Eppendorf) following the manufacturer’s instructions 
in an ABI PRISM 7500 Fast Sequence Detection System (Applied Biosystems, Carlsbad, California). 
Each reaction was performed in a final volume of 20 μL containing 10 μL PrimerDesign 2X 
Precision
TM MasterMix (Eppendorf), 1 μL Primer/probe Mix (300 nM final), 5 μL diluted cDNA and  Int. J. Mol. Sci. 2011, 12                 
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4 μL PCR-Grade water. No template controls contained only RNase/DNase-free water. Amplifications 
were performed starting with a 10 min at 95 °C for the enzyme activation, followed by 50 cycles of 
template denaturation step at 95 °C for 15 s, data collection at 50 °C for 30 s and extension at 72 °C for 
15 s. No-template control tubes (NTC), containing water instead of template mRNA, were also run 
under the same conditions for each gene. No product was synthesized in the NTC, so this indicated that 
the RT-qPCR reagents were not contaminated with the amplicon. 
4.3. Gene Expression Stability Analysis 
Data were analyzed transforming raw Cq values into relative quantification data using the deltaCq 
method. To achieve this, we subtracted the highest Cq value from all other Cq values for each gene 
measured. Hence each Cq value has been transformed into a “delta Cq” value, with the highest delta 
Cq value as 0. All other values are less than 0. Then for each data point, we applied the equation  
2
(−deltaCq). Hence all data is expressed relative to the expression of the least expressed gene. 
To determine the most stable reference genes, these data obtained have been converted to 
appropriate input files, according to the requirements of the programs, and processed by two different 
algorithms: geNorm v3.4 [12] and NormFinder v0.953 [13].  
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